The International Online Journal of Cancer & Therapeutics is a peer-reviewed open acess journal that publishes original research articles as well as review articles in all areas of Oncology. this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research. Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences The International Online Journal of Cancer & Therapeutics exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. This journal comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Oncology is the diagnosis and treatment of cancers,including breast,prostate,colon,lung and ovarian cancers as well as brain tumors,leukemia,lymphoma and many other types of cancer.. A doctor who works in the field of oncology is called an oncologist. The primary regions of oncology are radiation, which is worried with radiation treatment, or radiotherapy; surgical, which is contained specialists who spend significant time in tumor evacuation; therapeutic, which manages disease drugs, including chemotherapy; and interventional, which includes interventional radiologists who have some expertise in insignificantly obtrusive picture guided tumor treatment.


committee

Members

ThumbnailImage

Mohammad O Hoque

Associate Professor,

Dr. Hoque is an Associate Professor of Otolaryngology-Head & Neck Surgery, Urology and Oncology at Johns Hopkins University School of Medicine. He has published over 100 papers in reputed journals and has been serving as an editor and/or editorial board member of several bio-medical journals. He has been also serving in NIH and several grant review study sections.

 

 

Undergraduate
1980 S.S.C Dhaka Board, Bangladesh
1982 H.S.C Comilla Board, Bangladesh


Doctoral/graduate
1988 BDS Dentistry, Dhaka University, Bangladesh
1995 DDS Dentistry, Dhaka University, Bangladesh
1998 Ph. D Molecular Biology, Tokushima University, Japan


Postdoctoral
1988 -1989 Internship, Dhaka Dental College and Hospital
1989- 1991 Oral Surgery Training, Dhaka Dental College
1992-1993 Postgraduate student, Bangabandhu Sheikh Mujib Medical University, Dhaka
1993-1994 Japanese Language Student, Okayama University, Japan
1994-1998 Ph.D. Student, Tokushima University, Japan
1995-1997 Advanced Clinical Training in Oral and Maxillofacial Surgery and Oncology,
Tokushima University, Japan
1998-1999 Fuji Otsuka Research Fellow, Tokushima University, Japan
1999-2000 Japan Society for Promotion of Science (JSPS) Fellow, Tokushima University, Japan
2001- 6/06 Postdoctoral Fellow, Johns Hopkins University School of Medicine (SOM)

His major research interests includes:  

a) To understand molecular biologic basis of head and neck, lung and genitourinary cancer

b) To develop and validate genetic and epigenetic approach for early cancer diagnosis, cancer risk assessment and cancer prognosis and

c) To identify molecular alterations due to environmental exposures such as active smoking, passive smoking and arsenic.

  • 1983-1988 Dhaka Board and Dhaka University Outstanding student Scholarship
  • 1993-1998 Monbusho (Ministry of Education) Scholarship, Japan
  • 1998-1999 Fuji Otsuka International fellowship, Japan
  • 1999-200 JSPS (Japan Society for Promotion of Science) Fellowship, Japan
  • 2003 AACR–Busch Travel Fund Scholar-in-Training Award at 94th Annual Meeting of American Association for Cancer Research
  • 2004 AACR-Astra Zenaca Scholar-in-Training Award at 95th Annual Meeting of American Association for Cancer Research
  • 2006-2011 Young Clinical Scientist Award (FAMRI)
  • 2007- 2009 Young Investigator Award (IASLC)
  • 2008-2010 Career Development Award (Cervical Spore)
  • 7/10-6/11 Adjunct Associate Professor (non-paid), Faculty of Health and Medical Sciences, Gono Bishwabidyalay (University), Bangladesh.
  • 2013 Faculty Grant Award, Johns Hopkins Center for Global Health.
  • 2017 JSPS US Alumni Association Seminar Program 2017 grant award.